Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Old Republic International | ORI | Nov 29, 2024 | 38.97 | -0.03 |
Old Second Bancorp | OSBC | Nov 29, 2024 | 18.60 | -0.69 |
Olema Pharmaceuticals | OLMA | Nov 29, 2024 | 10.12 | 0.00 |
Olin | OLN | Nov 29, 2024 | 42.59 | -0.26 |
Ollies Bargain Oulet | OLLI | Nov 29, 2024 | 98.95 | -2.12 |
Olo A | OLO | Nov 29, 2024 | 7.29 | +0.41 |
Olympic Steel | ZEUS | Nov 29, 2024 | 42.28 | -0.07 |
Omega Flex | OFLX | Nov 29, 2024 | 49.42 | +0.37 |
Omega Healthcare Investors | OHI | Nov 29, 2024 | 40.61 | -0.15 |
Omega Therapeutics | OMGA | Nov 29, 2024 | 0.88 | +10.96 |
Omeros | OMER | Nov 29, 2024 | 11.35 | -4.70 |
OmniAb | OABI | Nov 29, 2024 | 3.91 | +0.26 |
Omnicell | OMCL | Nov 29, 2024 | 46.59 | -3.86 |
Omnicom Group | OMC | Nov 29, 2024 | 104.82 | +0.45 |
On Holding | ONON | Nov 29, 2024 | 58.33 | +0.74 |
ON Semiconductor | ON | Nov 29, 2024 | 71.12 | +1.09 |
ON24 | ONTF | Nov 29, 2024 | 6.61 | +0.46 |
OncoCyte | OCX | Nov 29, 2024 | 2.44 | +0.21 |
Oncolytics Biotech | ONCY | Nov 29, 2024 | 0.93 | +0.02 |
Onconetix | ONCO | Nov 29, 2024 | 0.69 | +4.23 |
Oncternal Therapeutics | ONCT | Nov 29, 2024 | 0.69 | -7.16 |
Ondas Holdings | ONDS | Nov 29, 2024 | 0.98 | +13.55 |
ONE Gas | OGS | Nov 29, 2024 | 77.97 | +0.49 |
One Liberty Properties | OLP | Nov 29, 2024 | 30.07 | -0.27 |
One Stop Systems | OSS | Nov 29, 2024 | 2.37 | +3.04 |
OneConnect Financial Technology ADR | OCFT | Nov 29, 2024 | 2.50 | +1.63 |
OneMain | OMF | Nov 29, 2024 | 57.35 | +0.67 |
OneMedNet | ONMD | Nov 29, 2024 | 0.94 | +3.87 |
ONEOK | OKE | Nov 29, 2024 | 113.60 | +0.90 |
OneSpan | OSPN | Nov 29, 2024 | 18.12 | -0.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.